KR20040039394A - 선택적 inos 억제제를 사용한 신경보호적 치료 방법 - Google Patents

선택적 inos 억제제를 사용한 신경보호적 치료 방법 Download PDF

Info

Publication number
KR20040039394A
KR20040039394A KR10-2004-7004170A KR20047004170A KR20040039394A KR 20040039394 A KR20040039394 A KR 20040039394A KR 20047004170 A KR20047004170 A KR 20047004170A KR 20040039394 A KR20040039394 A KR 20040039394A
Authority
KR
South Korea
Prior art keywords
alkyl
halo
alkoxy
product
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2004-7004170A
Other languages
English (en)
Korean (ko)
Inventor
매닝파멜라티
코너제인알
Original Assignee
파마시아 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파마시아 코포레이션 filed Critical 파마시아 코포레이션
Publication of KR20040039394A publication Critical patent/KR20040039394A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR10-2004-7004170A 2001-09-24 2002-09-24 선택적 inos 억제제를 사용한 신경보호적 치료 방법 Withdrawn KR20040039394A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/961,521 US20030119826A1 (en) 2001-09-24 2001-09-24 Neuroprotective treatment methods using selective iNOS inhibitors
US09/961,521 2001-09-24
PCT/US2002/030214 WO2003026638A1 (en) 2001-09-24 2002-09-24 Neuroprotective treatment methods using selective inos inhibitors

Publications (1)

Publication Number Publication Date
KR20040039394A true KR20040039394A (ko) 2004-05-10

Family

ID=25504581

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7004170A Withdrawn KR20040039394A (ko) 2001-09-24 2002-09-24 선택적 inos 억제제를 사용한 신경보호적 치료 방법

Country Status (13)

Country Link
US (1) US20030119826A1 (cg-RX-API-DMAC10.html)
EP (1) EP1429752A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005508910A (cg-RX-API-DMAC10.html)
KR (1) KR20040039394A (cg-RX-API-DMAC10.html)
CN (1) CN1556698A (cg-RX-API-DMAC10.html)
AU (1) AU2002327042A2 (cg-RX-API-DMAC10.html)
BR (1) BR0212989A (cg-RX-API-DMAC10.html)
CA (1) CA2455989A1 (cg-RX-API-DMAC10.html)
IL (1) IL161005A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA04002710A (cg-RX-API-DMAC10.html)
PL (1) PL371774A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003026638A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200402288B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
BRPI0617477A2 (pt) * 2005-10-19 2011-07-26 Teva Pharma mistura de partÍculas cristalinas de laquinimod sàdica, composiÇço, processo de cristalizaÇço de laquinimod sàdica, laquinimod sàdica, e, processo para produzir uma composiÇço farmacÊutica
CN101466379B (zh) 2006-06-12 2012-10-31 泰华制药工业有限公司 稳定的拉喹莫德的制剂
WO2009082471A1 (en) 2007-12-20 2009-07-02 Teva Pharmaceutical Industries, Ltd. Stable laquinimod preparations
AU2009288108B2 (en) * 2008-09-03 2013-10-17 Teva Pharmaceutical Industries, Ltd. 2-oxo-1,2-dihydro-quinoline modulators of immune function
BR112012002124A2 (pt) * 2009-07-30 2015-09-15 Teva Pharma tratamento da doença de crohn com laquinimode.
WO2011019375A1 (en) * 2009-08-10 2011-02-17 Teva Pharmaceutical Industries Ltd. Treatment of bdnf-related disorders using laquinimod
SG11201401330YA (en) 2011-10-12 2014-05-29 Teva Pharma Treatment of multiple sclerosis with combination of laquinimod and fingolimod
WO2013116657A1 (en) 2012-02-03 2013-08-08 Teva Pharmaceutical Industries Ltd. USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
EA201590788A1 (ru) 2012-11-07 2015-12-30 Тева Фармасьютикал Индастриз Лтд. Аминные соли лахинимода
JP2016514162A (ja) 2013-03-14 2016-05-19 テバ ファーマシューティカル インダストリーズ リミティド ラキニモドナトリウムの結晶およびその製造のための改善された方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586474B2 (en) * 2000-03-24 2003-07-01 Pharmacia Corporation Amidino compounds useful as nitric oxide synthase inhibitors
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa

Also Published As

Publication number Publication date
US20030119826A1 (en) 2003-06-26
CN1556698A (zh) 2004-12-22
PL371774A1 (en) 2005-06-27
CA2455989A1 (en) 2003-04-03
MXPA04002710A (es) 2004-07-05
BR0212989A (pt) 2005-04-26
IL161005A0 (en) 2004-08-31
WO2003026638A1 (en) 2003-04-03
AU2002327042A2 (en) 2003-04-07
JP2005508910A (ja) 2005-04-07
ZA200402288B (en) 2006-12-27
EP1429752A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
US11679090B2 (en) Modulators of Sestrin-GATOR2 interaction and uses thereof
US20130281449A1 (en) Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
US20050203082A1 (en) Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
US20030119826A1 (en) Neuroprotective treatment methods using selective iNOS inhibitors
WO2003097050A2 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
US20040077639A1 (en) Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
KR20040039393A (ko) 선택적 inos 억제제를 사용한 안과적 치료 방법
KR20050059051A (ko) 위장 증상의 치료 및 예방 방법
CN104203922A (zh) 螺乙内酰脲化合物及其作为选择性雄激素受体调节剂的用途
JP2005506986A5 (cg-RX-API-DMAC10.html)
HK1070278A (en) Neuroprotective treatment methods using selective inos inhibitors

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040322

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid